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and greater numbers with casual partners,
14/35 (40%) v 1/20 (5%), in those attending
the hospital based clinic compared with
outreach patients. Interviewees reported that
location played an important part in their
decision as to which site to attend as 46/55
(83%) attended the clinic that was closest to
home or work. Lack of awareness of alterna-
tive clinics did not seem to be a significant
factor influencing the site attended, as 34/55
(62%) were aware of alternatives. Confiden-
tiality and stigma were not stated as impor-
tant issues.
Demographic and disease data on 209 con-
secutive attendees at the hospital based clinic
and 111 consecutive attendees at the outreach
clinic in 2001 were compared (table 1). The
data show that outreach patients were more
likely to be teenagers, women, African, and
first time clinic attendees. STD rates were
similar at both sites. These data are similar to
those obtained in 1998 although the ethnic
mix has changed.
It has long been assumed that stigma and
confidentiality were the main influences on
patient access to GUM services and ever since
the Monk report there has been a move
towards overcoming these barriers.5 This
study shows that the outreach service at-
tracted a new and very different population,
in terms of demographics and GUM experi-
ence, but the overriding influence on the
patients’ choice of site of care was closeness
to home or work. However, outreach services
such as this are also relatively time consum-
ing and expensive compared with the larger
clinic. These factors should be strongly
considered when developing new outreach
services.
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Clearance of HPV infection in
middle aged men and women
after 9 years’ follow up
The age prevalence of human papillomavirus
(HPV) cervical infections is high in young age
groups, declining sharply thereafter, reaching
a steady state after age 40.1 Women who
remain persistent carriers of HPV DNA are
considered at high risk for cervical cancer. To
investigate viral persistence over an extended
period of time, we re-contacted, in 1997–8, a
group of women who participated in case-
control studies between 1988–91 in Spain,
Colombia, and Brazil.2–4 Among women with
confirmed normal cervical smears, follow up
was scheduled for all women positive for HPV
cervical detection (n=91) and for a group of
age matched women who were HPV negative
(n=254). All but one HPV infection were of
high risk types. Husbands of these women in
Colombia and in Spain, initially detected to be
HPV positive (n=110), were also re-contacted.
Follow up data were obtained from personal
interview and from HPV DNA tested in cervi-
cal and urethral (men) exfoliated cells. The
follow up protocol was approved by the insti-
tution’s ethics committee and participants
signed an informed consent. Finally, 198
women (57.4%) and 42 (38.2%) men were
re-interviewed. Of them, 99 women provided
cervical samples and 14 men provided ure-
thral samples. HPV detection was carried out
in the same laboratories that tested the initial
samples. The Spanish and Colombian samples
were tested using the PMY09/11 PCR L1 based
method and the Brazilian samples were tested
using the GP5+/6+ PCR system.
The average age at entry was 50.8 years for
women and 51.9 for men (range 27–79 years).
After an average of 9 years of follow up (range
7–11), none of the women examined har-
boured HPV DNA irrespective of their initial
HPV status (table 1). The follow up cervical
smear identified three women in Colombia
and one in Brazil with a cervical intraepithe-
lial neoplasm grade I. All were HPV negative.
Among the HPV positive husbands who were
re-examined, two remained positive (14.3%,
95% CI 3.7 to 32.6), one for low risk type HPV
6 and one for high risk type HPV 16. No penile
lesions were detected upon clinical examina-
tion. An active search in the corresponding
cancer registries did not identify any case of
invasive cervical or penile cancer in the target
population.
The data, albeit limited by small size,
suggest that HPV infection in middle age is
subject to clearance as is commonly observed
in young women.4 All women with follow up
information had no HPV infection after an
average follow up period of 9 years. None of
the women developed advanced cervical dis-
ease in the interval as would be expected in
some cases of chronic carriers of HPV
infection.
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Table 1 HPV detection in women and men at entry and at follow up time
Spain Colombia Brazil All
Women:
HPV status at entry
Negative 13 31 35 79
Positive 3 5* 12 20
HPV status at follow up
Negative 16 36 47 99
Positive 0 0 0 0
Men:
HPV status at entry
Positive 9 5 – 14
HPV status at follow up
Positive 1** 1*** – 2
Negative 8 4 – 12
*One women was positive for a low risk HPV DNA, **HPV 6, ***HPV 16.
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